Generate a tailored SOP for Dr. Garret Fitzgerald. Improve your application with a focused, well-structured draft.
Garret FitzGerald, M.D., FRS, is the Robert L. McNeil, Jr. Professor of Translational Medicine and Therapeutics at the University of Pennsylvania’s Perelman School of Medicine. He is the Associate Dean for Translational Research and the Director of the Institute for Translational Medicine and Therapeutics. With expertise in prostanoid biology, cardiovascular biology, metabolism, and aging, FitzGerald's research focuses on the role of peripheral molecular clocks in drug efficacy and therapeutic interventions. He integrates systems approaches to study the interdisciplinary aspects of translational science, exploring how molecular mechanisms impact health outcomes in humans. His lab utilizes mammalian cells, fish, and mouse models to decipher the complex biology of drug action in specific contexts. FitzGerald has contributed significantly to understanding the effects of cyclooxygenase inhibitors on cardiovascular responses. His work has been published in top journals and he has received numerous accolades for his contributions to medicine and translational research.
Wharton Doctoral programs cover fields like Finance, Marketing, Management, and Operations, Information and Decisions.